Alniche Life Sciences Pvt Ltd

COMBISAFE Tablet 10's

Supplements
MRP ₹264.00 (Inclusive of all taxes)
New Reduced MRP as per revised GST benefit.
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About COMBISAFE TABLET

    COMBISAFE Tablet is a nutritional supplement used to improve the health of your brain and nervous system. It manages nerve damage, improves your memory and cognitive functions (learning, thinking, reasoning, decision making, etc.) and controls abnormal mood changes (such as anxiety, depression, etc.). It contains Methylcobalamin, Alpha lipoic acid, Benfotiamine, Folic acid, Chromium polynicotinate, Inositol and Pyridoxine as active ingredients.

    The antioxidant effects of alpha lipoic acid manage nerve cells from getting damaged due to toxin accumulation. This action plays a vital role in reducing the onset of age-related memory problems and other neurodegenerative diseases. It also has the capacity to repair damaged brain cells.

    Methylcobalamin is essential for the formation of a protective covering called myelin sheath around the nerves, a lack of which leads to nerve pain and sensitivity. They also offer protection to the brain cells from getting damaged. Benfotiamine, folic acid and inositol improves nerve health and protects your nerves from becoming more sensitive. Chromium and pyridoxine improve your mood and reduce the signs of anxiety and depression.

    Take COMBISAFE Tablet as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Before taking COMBISAFE Tablet inform your doctor if you are pregnant or breastfeeding or having any pre-existing disease conditions as a precaution.

    Key Composition

    • Methylcobalamin
    • Alpha lipoic acid
    • Benfotiamine
    • Folic acid
    • Chromium polynicotinate
    • Inositol
    • Pyridoxine

    Author Details

    Written By Srilekha. R - B.Pharm
    Reviewed For Accuracy By Dr. Narayanasetty Sai Swaroop - Pharm.D
    Last updated on 20 May 2023 | 11:50 AM(IST)
    Lab updated